Early graft of neural precursors in spinal cord compression reduces glial cyst and improves function

被引:17
作者
Boido, Marina [1 ]
Garbossa, Diego [2 ]
Vercelli, Alessandro [1 ]
机构
[1] Cavalieri Ottolenghi Fdn, Inst Neurosci, Neurosci Inst Turin, I-10043 Turin, Italy
[2] Univ Turin, Dept Neurosci, I-10124 Turin, Italy
关键词
spinal cord injury; cell therapy; CNS repair; glial cyst; CEREBRAL-ARTERY OCCLUSION; STEM-CELLS; REACTIVE ASTROCYTES; RESTRICTED PRECURSORS; TRANSPLANTATION; INJURY; MOUSE; RECOVERY; SURVIVAL; NEURONS;
D O I
10.3171/2011.1.SPINE10607
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. Spinal cord injury (SCI) often results in irreversible and permanent neurological deficits below the injury site and is considered a pathological state of functional damage to local neurons and axon fibers. There are several experimental treatments to minimize tissue damage, and recently cell transplantation has emerged as a promising approach in spinal cord repair. The authors undertook this study to evaluate grafting of neural tube precursors as a possible therapeutic strategy in a model of spinal cord compression in the mouse. Methods. Compression SCI was induced at the T-13 level in adult male mice. Immediately after injury, neural precursor cells (NPs) were transplanted into the SCI lesion cavity in 18 mice; the remaining 19 mice received saline injections into the lesion cavity and were used as controls. Spinal cords were examined 12,19, and 26 days postinjury to investigate the survival of the NPs and their effects on the cellular environment, glial scar and glial cyst formation, astrogliosis, and microglial activation. Results. Grafted NPs survived well and integrated into the host spinal cord tissue. Some NPs had differentiated into cells expressing glial and neuronal markers at all 3 end points. Analysis of glial cyst volume showed a lesion volume reduction of 63.2% in the NP-treated mice compared with volume in the injured but untreated mice. There appeared to be no difference in astroglial and microglial activation between untreated mice and treated ones. Sensory and motor tests demonstrated that transplantation of NPs promoted improvement in injured and treated animals compared with controls. Conclusions. These results support the therapeutic potential of NPs, demonstrating that they can survive for a long time, differentiate, integrate into the injured spinal cord, and promote functional recovery after SCI. (DOI: 10.3171/2011.1.SPINE10607)
引用
收藏
页码:97 / 106
页数:10
相关论文
共 58 条
[1]   Schwann cell precursors transplanted into the injured spinal cord multiply, integrate and are permissive for axon growth [J].
Agudo, M. ;
Woodhoo, A. ;
Webber, D. ;
Mirsky, R. ;
Jessen, K. R. ;
McMahon, S. B. .
GLIA, 2008, 56 (12) :1263-1270
[2]  
Barami K, 2000, NEUROSURGERY, V47, P691
[3]   Motoneurons crave glial cell line-derived neurotrophic factor [J].
Bohn, MC .
EXPERIMENTAL NEUROLOGY, 2004, 190 (02) :263-275
[4]   Embryonic and adult stem cells promote raphespinal axon outgrowth and improve functional outcome following spinal hemisection in mice [J].
Boido, Marina ;
Rupa, Rosita ;
Garbossa, Diego ;
Fontanella, Marco ;
Ducati, Alessandro ;
Vercelli, Alessandro .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2009, 30 (05) :833-846
[5]  
Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO
[6]  
2-E
[7]   Differentiation of engrafted neuronal-restricted precursor cells is inhibited in the traumatically injured spinal cord [J].
Cao, QL ;
Howard, RM ;
Dennison, JB ;
Whittemore, SR .
EXPERIMENTAL NEUROLOGY, 2002, 177 (02) :349-359
[8]   Stem cells for the treatment of spinal cord injury [J].
Coutts, Margaret ;
Keirstead, Hans S. .
EXPERIMENTAL NEUROLOGY, 2008, 209 (02) :368-377
[9]   The microglial networks of the brain and their role in neuronal network plasticity after lesion [J].
Cullheim, Staffan ;
Thams, Sebastian .
BRAIN RESEARCH REVIEWS, 2007, 55 (01) :89-96
[10]   Acute spinal cord injury, part I: Pathophysiologic mechanisms [J].
Dumont, RJ ;
Okonkwo, DO ;
Verma, RS ;
Hurlbert, RJ ;
Boulos, PT ;
Ellegala, DB ;
Dumont, AS .
CLINICAL NEUROPHARMACOLOGY, 2001, 24 (05) :254-264